10x Genomics第四季度每股收益$(0.40)未达预期$(0.30),销售额$1.6502亿超预期$1.5939亿

财报速递2025-02-13
10x Genomics (NASDAQ:TXG)报告季度每股亏损$(0.40),未达到分析师预期的$(0.30),低了33.33%。与去年同期每股亏损$(0.24)相比,下降了66.67%。公司报告季度销售额为1.6502亿美元,超过了分析师预期的1.5939亿美元,高出3.53%。与去年同期销售额1.8398亿美元相比,下降了10.30%。

以上内容来自Benzinga Earnings专栏,原文如下:

10x Genomics (NASDAQ:TXG) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.30) by 33.33 percent. This is a 66.67 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $165.02 million which beat the analyst consensus estimate of $159.39 million by 3.53 percent. This is a 10.30 percent decrease over sales of $183.98 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法